CO2022014130A2 - Cápsulas de gel blando - Google Patents

Cápsulas de gel blando

Info

Publication number
CO2022014130A2
CO2022014130A2 CONC2022/0014130A CO2022014130A CO2022014130A2 CO 2022014130 A2 CO2022014130 A2 CO 2022014130A2 CO 2022014130 A CO2022014130 A CO 2022014130A CO 2022014130 A2 CO2022014130 A2 CO 2022014130A2
Authority
CO
Colombia
Prior art keywords
soft gel
gel capsules
shell composition
solubilizes
certain embodiments
Prior art date
Application number
CONC2022/0014130A
Other languages
English (en)
Inventor
Rickey Steve Shelley
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of CO2022014130A2 publication Critical patent/CO2022014130A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

En ciertas modalidades se divulga una cápsula de gel blando que comprende (a) un material de relleno; y (b) una composición de cubierta, en donde el material de relleno comprende al menos 10 % de un medio líquido, y en donde la composición de cubierta comprende gelatina y un polímero dependiente de pH que se solubiliza a un pH de menos de aproximadamente 6.0.
CONC2022/0014130A 2020-03-18 2022-09-30 Cápsulas de gel blando CO2022014130A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062991354P 2020-03-18 2020-03-18
PCT/US2021/022918 WO2021188773A1 (en) 2020-03-18 2021-03-18 Softgel capsules

Publications (1)

Publication Number Publication Date
CO2022014130A2 true CO2022014130A2 (es) 2022-10-31

Family

ID=77771391

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0014130A CO2022014130A2 (es) 2020-03-18 2022-09-30 Cápsulas de gel blando

Country Status (11)

Country Link
US (1) US20230172864A1 (es)
EP (1) EP4121036A4 (es)
JP (1) JP2023518245A (es)
KR (1) KR20220154196A (es)
AR (1) AR121608A1 (es)
AU (1) AU2021238345A1 (es)
BR (1) BR112022018268A2 (es)
CA (1) CA3171512A1 (es)
CO (1) CO2022014130A2 (es)
MX (1) MX2022011549A (es)
WO (1) WO2021188773A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20022777A1 (it) * 2002-12-27 2004-06-28 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
CN1872061A (zh) * 2006-04-17 2006-12-06 宛六一 一种药物组合物软胶囊及其制备方法
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
US20180049999A1 (en) * 2015-04-14 2018-02-22 Atossa Genetics Inc. Compositions and methods of treatment of breast disorders and estrogen-related disorders
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
IT201800003615A1 (it) * 2018-03-15 2019-09-15 Altergon Sa Formulazioni altamente stabili di ormone tiroideo in capsule molli
AU2019236237A1 (en) * 2018-03-15 2020-09-17 R.P. Scherer Technologies, Llc Enteric softgel capsules

Also Published As

Publication number Publication date
CA3171512A1 (en) 2022-09-23
EP4121036A1 (en) 2023-01-25
AU2021238345A1 (en) 2022-10-06
KR20220154196A (ko) 2022-11-21
EP4121036A4 (en) 2024-04-10
AR121608A1 (es) 2022-06-22
WO2021188773A1 (en) 2021-09-23
BR112022018268A2 (pt) 2022-10-25
MX2022011549A (es) 2022-10-13
JP2023518245A (ja) 2023-04-28
US20230172864A1 (en) 2023-06-08

Similar Documents

Publication Publication Date Title
Nutting et al. Chemical bleaching of discolored endodontically treated teeth
CY1118258T1 (el) Εντεροδιαλυτη συνθεση για την παρασκευη περιβληματος μαλακης καψουλας
FI944452A (fi) Gelatiinikapseli ja menetelmä sen valmistamiseksi
HUP9701111A2 (hu) Töltőanyag lágy zselatin kapszula gyógyszeradagolási formához
ES8503508A1 (es) Una forma de dosificacion unitaria farmaceutica
AR051237A1 (es) Sistema de capsula blanda sin gelatina
CO5640066A2 (es) Composicion oral que contiene enzimas con estabilidad mejorada
BRPI0415014A (pt) formulações em multipartìculas de pantoprazol, cápsula e embalagem que as compreendem, método de produção das formulações, uso e composição
HUP0104161A2 (hu) Javított stabilitású, peptidalapú trombin inhibitort tartalmazó injekciós oldatok és eljárás az előállításukra
CO2022014130A2 (es) Cápsulas de gel blando
ATE252376T1 (de) Retinolhaltiges arzneimittel kompatibel mit weichgelatinekapseln
EP0152292A3 (en) Acetaminophen gelatin capsules
ATE252893T1 (de) Vitamin zusammensetzung
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
ATE392204T1 (de) Neue formulierungen für retinoid-haltige weichgelatinekapseln
WO2003013717A3 (en) Improvements in or relating to encapsulation
BR0312875A (pt) Cápsula de gelatina resistente à pelìcula
Bachour et al. Evaluation of the rupture test for stability studies of soft-shell capsules
Hanson Three new saprophytic chytrids
MX2023004441A (es) Composiciones de relleno de liberacion controlada y capsulas que las contienen.
BRPI0415957A (pt) aparelho e método para selar uma embalagem
CO2021012391A2 (es) Estabilidad api mejorada en capsulas blandas
MX2023005641A (es) Forma de dosificacion en capsula de gelatina blanda de talazoparib.
KR960006909A (ko) 화장료용 콜라겐 캡슐
TH18313A (th) ผลิตภัณฑ์ทางเภสัชกรรม